Literature DB >> 6814602

Yersinia and chronic glomerulopathy in the savannah region of Nigeria.

C Awunor-Renner, R V Lawande.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6814602      PMCID: PMC1500587          DOI: 10.1136/bmj.285.6353.1464

Source DB:  PubMed          Journal:  Br Med J (Clin Res Ed)        ISSN: 0267-0623


× No keyword cloud information.
  4 in total

1.  Yersiniosis as an internal disease.

Authors:  R Leino; J L Kalliomäki
Journal:  Ann Intern Med       Date:  1974-10       Impact factor: 25.391

2.  Yersinia enterocolitica and glomerulonephritis.

Authors:  M Friedberg; S Larsen; T Denneberg
Journal:  Lancet       Date:  1978-03-04       Impact factor: 79.321

3.  Glomerulonephritis in infections with Yersinia enterocolitica O-serotype 3. II. The incidence and immunological features of Yersinia infection in a consecutive glomerulonephritis population.

Authors:  M Friedberg; T Denneberg; C Brun; J H Larsen; S Larsen
Journal:  Acta Med Scand       Date:  1981

4.  Glomerulonephritis in infections with Yersinia enterocolitica O-serotype 3. I. Evidence for glomerular involvement in acute cases of yersiniosis.

Authors:  T Denneberg; M Friedberg; T Samuelsson; S Winblad
Journal:  Acta Med Scand       Date:  1981
  4 in total
  4 in total

1.  Cultural and serological studies of yersiniosis in camels in Nigeria.

Authors:  J P Kwaga; A A Adesiyun; L H Lombin; S M Mijinyawa; D E Agbonlahor
Journal:  Can Vet J       Date:  1987-01       Impact factor: 1.008

2.  Acute renal failure following Yersinia pseudotuberculosis septicaemia.

Authors:  A Davenport; B O'Connor; R Finn
Journal:  Postgrad Med J       Date:  1987-09       Impact factor: 2.401

3.  Characteristics of Yersinia intermedia-like bacteria isolated from patients with diarrhea in Nigeria.

Authors:  D E Agbonlahor
Journal:  J Clin Microbiol       Date:  1986-05       Impact factor: 5.948

4.  Attempt of Yersinia enterocolitica isolation from human feces in Senegal.

Authors:  L Franzin; G Di Rosa; A Sinicco
Journal:  Eur J Epidemiol       Date:  1987-12       Impact factor: 8.082

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.